Los Angeles, CA
Tr1x develops cellular therapies intended for the treatment of autoimmune disorders. The company utilizes its exclusive platform to produce cutting-edge cell therapy products designed to recalibrate the immune system and reinstate homeostasis, ultimately fostering long-term tolerance.
tr1x.bioThese are collections Tr1x is a part of. Click on the collection name to view similar companies.
Grant
$8,000,000
Series A
$75,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Tr1x.